F260-0198 Screening compound: N-(2-methanesulfonamido-1,3-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

F260-0198 Screening compound: N-(2-methanesulfonamido-1,3-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
F260-0198 Screening compound: N-(2-methanesulfonamido-1,3-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F260-0198
N-(2-methanesulfonamido-1,3-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F260-0198

Molecular Formula

C20H19N5O4S2 (C20 H19 N5 O4 S2)

Compound Name

N-(2-methanesulfonamido-1,3-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

IUPAC name

N-(2-methanesulfonamido-13-benzothiazol-6-yl)-3-[3-(4-methylphenyl)-124-oxadiazol-5-yl]propanamide

SMILES

Cc(cc1)ccc1-c1noc(CCC(Nc(cc2)cc3c2nc(NS(C)(=O)=O)s3)=O)n1

InChI

InChI=1S/C20H19N5O4S2/c1-12-3-5-13(6-4-12)19-23-18(29-24-19)10-9-17(26)21-14-7-8-15-16(11-14)30-20(22-15)25-31(2,27)28/h3-8,11H,9-10H2,1-2H3,(H,21,26)(H,22,25)

InChI Key

RNGAXQPKAFQECV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111081

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.53

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.005

Distribution Coefficient, logD

3.873

Water Solubility, LogSw

-4.10

Polar Surface Area

106.088

Acid Dissociation Constant (pKa)

7.85

Base Dissociation Constant (pKb)

0.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

F260-0198 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with F260-0198 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F260-0198?
Check Price and Availability of F260-0198, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F260-0198 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F260-0198
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F260-0198
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F260-0198 available by request